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1. ABSTRACT
The psychological impact of genetic testing for an inherited arrhythmia and its influence
on future well-being is highly variable and has not been well studied. Thirty-seven participants
completed a survey which included questions from the Multidimensional Impact of Cancer Risk
Assessment (MICRA) questionnaire, Impact of Events Scale (IES) and Satisfaction with
Decision Scale (SWDS) to provide more information on their genetic testing experience and to
allow the authors to search for trends that may improve the genetic counseling experience
moving forward. Trends were seen upon the comparison of those who had positive versus
negative genetic testing results. Those with positive test results seemed to have higher stress
scores and experienced a greater psychological impact. While more investigation is needed, this
study serves as a good starting point to understanding the experience of genetic testing for these
individuals.
Keywords: Cardiac Arrhythmias, Genetic Testing, Psychological Impact

2. INTRODUCTION
In recent years, genetic testing has become widespread in its application within
healthcare specialties that involve potentially heritable disorders. Several factors have
contributed to it becoming a more accessible tool in the management and care of families with
inherited conditions including advances in disease gene identification, the declining cost of
genetic testing and laws that protect patients from being discriminated against by employers and
health care providers based on genetic testing results. Cardiac genetics in particular is a growing
field that can provide more information to families with a suspected inherited cardiac condition.

There are many reasons why someone may choose to undergo genetic testing for cardiac
conditions such as long QT syndrome (LQTS), short QT syndrome (SQTS), catecholaminergic
polymorphic ventricular tachycardia (CPVT) or Brugada syndrome (BS). The major benefits of
testing are enhanced medical management guidance and the ability to recommend medications or
other interventions to prevent sudden cardiac death (SCD). It can also be used to confirm a
diagnosis in an individual who is symptomatic, or to provide a more accurate risk assessment for
asymptomatic family members. When deciding whether to have a genetic test, it is important that
individuals consider not only the medical benefits, but also the potential emotional impact. By
recognizing certain characteristics associated with negative psychological well-being following a
positive genetic test result, genetic counselors can address these issues during pre-test sessions to
better prepare patients for the potential impact of this result. Resources can also be put in place to
assist individuals who are struggling to cope with this new information. Overall, improved
understanding of the psychological implications of genetic testing in families with inherited
cardiac conditions and the effect that testing can have on health-related quality of life (HR-QoL)
can help tailor pre-test genetic counseling to best meet the needs of the patient.

3. BACKGROUND
Sudden cardiac death and primary arrhythmic disorders
Sudden cardiac death is defined as a natural, unexpected death due to abrupt loss of heart
function in an otherwise healthy individual. It typically occurs within an hour after the onset of
symptoms, although it can also occur without any warning symptoms at all. Each year, more than
300,000 people die of SCD in the United States alone, making it a major health concern not only
in the United States, but also worldwide (Fishman et al., 2010). A subset of SCD is the result of

a heart rhythm disorder known as an arrhythmia, which is defined as an irregular heartbeat
(Sarkozy & Brugada, 2005). Accordingly, the ability to identify an inherited arrhythmic
condition within a family may aid in the treatment and prevention of numerous SCDs.
Inherited arrhythmic conditions, also known as primary arrhythmic disorders, are a group
of monogenic syndromes characterized by genetic and pathophysiological heterogeneity. Despite
their unique clinical presentation, the syndromes share many common genetic counseling issues
including an autosomal dominant pattern of inheritance, variable age of onset, incomplete
penetrance, and increased risk of SCD (Ingles et al., 2012). The understanding of primary
arrhythmic disorders has advanced significantly in the last 20 years due to the discovery of
mutations in ion channel genes. This gives a genetic basis to a number of these disorders, many
of which were previously considered to be idiopathic. Genetic mutations in ion channel genes
alter the proper movement of ions through highly regulated channels that generate cardiac action
potentials, leading to dysfunction which can manifest itself as electrocardiogram (ECG)
abnormalities, arrhythmias and sudden death. Syndromes characterized by ion channel
dysfunction, commonly referred to as “channelopathies”, have been the focus of numerous
studies following the identification of ion channel mutations which underlie specific heritable
arrhythmic disorders. These include LQTS, BS, SQTS and CPVT (Wilde & Bezzina, 2005).
Psychological effect of genetic testing
Although genetic testing for some conditions has the potential to lower related morbidity
and mortality rates through increased surveillance and treatment, studies have questioned
whether it may also lead to increased distress, anxiety, depression and worry. Conditions that
exhibit reduced penetrance, such as inherited cancer syndromes or inherited cardiac disease,
appear to be of particular interest since test results only indicate a predisposition rather than a

definite diagnosis (Heshka, Palleschi, Howley, Wilson & Wells, 2008). At this time, there is not
a significant amount of literature that examines the psychological impact of cardiac genetic
testing. However, much has been published on psychological well-being for those who have
genetic testing for inherited cancer predispositions. There are similarities between the two patient
populations, allowing the extensive cancer research to help inform research on the psychological
effect of cardiac genetic testing.
Genetic testing for inherited cancer syndromes
Most short term studies noted, regardless of a patient's test result, whether positive,
negative or a variant of uncertain significance (VUS), that by the end of the follow-up time
period of one year, levels of psychological distress regarding BRCA1/2 testing were stable
(Graves et al., 2012).
Longer term follow-up prospective studies did find, however, that the level of distress in
mutation carriers can be elevated above what is seen in a control group, or a group of women
who tested negative. Graves et al. found that, about five years after genetic testing was
conducted, women who received a positive result reported greater distress from the test than
those who received a negative or uninformative result. The authors attributed this difference to
the sensitivity of the instrument, the MICRA (Multidimensional Assessment of Cancer Risk
Assessment) questionnaire, which was used to look at distress, uncertainty and positive
experiences related to genetic testing (Graves et al., 2012).
The impact that a genetic testing result has on an individual is also dependent on their
baseline level of anxiety and worry coming into the appointment, which is thought to be the most
robust predictor of psychological well-being. Factors that can cause increased anxiety or worry
include

a

history of

clinical

depression,

psychiatric

major

or

minor

depression,

psychopharmacologic medication use, higher pre-test anxiety, and higher levels of distress at the
time of testing (Hirschberg et al., 2015).
In 2009, a study by Ertmanski et al. looked to analyze the levels of pre-test and post-test
anxiety in women. According to the study, levels of anxiety following genetic testing were
similar to the levels of anxiety before testing. That level tended to remain elevated following the
receipt of a positive genetic testing result. No increased anxiety was associated with the news of
a positive genetic testing result, but no decline was seen either (Ertmanski et al., 2009).
The type of coping mechanism a patient uses to deal with genetic testing information will
affect their level of anxiety as well. Passive coping, where individuals rely on others to resolve
stress, is associated with increased stress and is connected to future distress for the patient.
Avoidant coping can also be associated with future distress, irrespective of a patient's genetic test
result or health history (Hirschberg et al., 2015). Those who are more aware of their risk going
into genetic counseling and genetic testing reported lower distress following the results (Marteau
& Croyle, 1998).
Genetic testing for inherited cardiac conditions
Although the majority of published studies that examine the psychological implications
of having genetic testing predominantly focus on inherited cancer syndromes, the literature has
started to examine these measures for more common cardiac conditions such as hypertrophic
cardiomyopathy (HCM) and LQTS in recent years.
A cross-sectional study by Christiaans et al. found that quality of life and psychological
distress in 228 HCM mutation carriers did not differ from the general Dutch population and in
fact, HCM mutation carriers without symptoms had even higher quality of life than the general
Dutch population. They also suggested that genetic testing had no adverse effects on these

measures, and may have even improved them. Several study participants spoke to the benefits of
knowing their genetic test results with one saying, “Since I received my DNA test result, I have
found more peace and I am more positive,” suggesting they have less distress and a better quality
of life after genetic testing (Christiaans et al., 2009).
Similarly, a longitudinal pilot study by Ingles et al. examined changes in HR-QoL of 33
patients and 21 family members undergoing predictive genetic testing for an inherited
cardiomyopathy or primary arrhythmic disorder. This study found that physical and mental
health scores analyzed at baseline and one to three months after testing were unchanged in
participants, regardless of their mutation status. Additionally, no changes in HR-QoL were
observed in the participants following genetic testing and up to 12 months after results disclosure
regardless of their mutation status (Ingles et al., 2012).
Hendriks et al. assessed the extent and course of disease-related anxiety and depression,
caused by predictive genetic testing in 77 patients and 57 partners from the time of first
consultation until 18 months after the disclosure of the result of genetic testing. In an initial
consultation, family history and ECG results were used to give individuals a presumptive
diagnosis. This study found that individuals with an uncertain ECG result had higher levels of
depression than those with a normal or even an abnormal ECG. They also found that after
disclosure of the genetic testing results, carriers had higher anxiety than non-carriers, especially
among those who had had an uncertain ECG result. Overall, this study found that individuals
who underwent predictive genetic testing experienced higher levels of distress initially, but
distress levels were essentially restored within 18 months of results disclosure, unless the patient
was also found to have an uncertain ECG, in which case the higher levels of distress persisted
(Hendriks et al., 2008).

Purpose
Current studies suggest that genetic testing, accompanied by genetic counseling, for
inherited cancer syndromes or cardiac conditions does not appear to have any long term impact
on psychological well-being or quality of life, regardless of mutation status. Despite this, very
little research has examined the psychological impact of genetic testing for primary arrhythmic
disorders such as LQTS, SQTS, CPVT or BS which may present differently with regard to
treatment, prognosis, time of onset and associated symptoms. Despite the ability to utilize the
current knowledge on inherited cancer syndromes to guide a hypothesis with respect to
arrhythmias, no research has been done to directly address this question. This study examines the
psychological well-being and HR-QoL of adults who had genetic testing for LQTS, SQTS,
CPVT or BS and further describes this population by analyzing responses to questions from
validated instruments including the Impact of Events Scale (IES), the Satisfaction with Decision
Scale (SWDS) and the MICRA questionnaire.

4. METHODS
This is a qualitative, survey-based study that examines the impact that genetic testing has
on an individual’s psychological well-being and their HR-QoL. Psychological well-being is
assessed through scales that measure anxiety, depression, parenting stress and decision regret.
HR-QoL is assessed through examinations of family functioning, marital relationships, selfinflicted restrictions and life-planning decisions.
Columbia University Medical Center’s study was approved by the Columbia University
Institutional Review Board and the current study was approved by the Sarah Lawrence College
Institutional Review Board.

Participants
Participants are Dr. Wendy Chung’s clinical patients and their family members who were
referred for genetic testing for arrhythmic disorders over the last six years. Inclusion criteria
include an appointment in the past 12 years for a personal or family history of BS, LQTS, CPVT
or SQTS. Exclusion criteria include inability to speak/read English, no working contact phone
number or a non-genetic systemic disease causing cardiac findings (i.e. myocarditis). Study
participants include: adults (greater than 18 years of age) who are symptomatic with evidence of
cardiac disease or asymptomatic with a known family history of cardiac disease; adults (greater
than 18 years of age) who are a spouse or significant other to an individual with a known family
history of cardiac disease; adolescents (greater than 13 years of age, but less than 18 years of
age) who are symptomatic with evidence of cardiac disease or asymptomatic with a known
family history of cardiac disease; and parents of children (younger than 13 years of age) who are
symptomatic with evidence of cardiac disease or asymptomatic with a known family history of
cardiac disease.
Data collection
Participants were identified through an existing clinical database of patients evaluated at
Columbia University Medical Center Clinical Genetics for an inherited cardiac condition.
Eligible participants were sent invitation letters from Dr. Wendy Chung which outlined the
proposed study. One letter was sent to each household, which sometimes included multiple
individuals who were eligible to participate. The letter was followed by up to five telephone calls
or emails from a research coordinator to invite the individual and their eligible family members
to participate. Individuals who did not respond to five follow-up phone calls or emails were
considered to have passively declined participation. A passive decline was considered

“confirmed” if it was verified that this was the correct number for the individual trying to be
reached (i.e. name in the voicemail, spoke to someone in the household). A passive decline was
considered “unconfirmed” if the phone number for the individual trying to be reached was not
verified (i.e. no name in the voicemail message). Individuals who responded that they did not
want to complete the survey were considered to have actively declined from participating.
The survey could be completed online, over the phone or by paper in written format.
Verbal consent to participate was obtained by telephone by the research coordinator for all
participants. For participants who chose to complete a paper survey, the consent form was mailed
to them with the questionnaire. For those who chose to complete the survey online at
surveymonkey.com, the consent form appeared prior to the start of the questions. Individuals
who completed the survey were compensated with a $20 gift card for each questionnaire
completed. The survey became available on October 8, 2015. At this time, there is no planned
end date. Data for analysis was collected between October 8, 2015 and March 7, 2016.
Study instruments
This study utilized four questionnaires that are unique to the groups of individuals
completing them. The four groups are: adults with a personal or family history of arrhythmias,
adults who married into a family with a history of arrhythmias, adolescents with a personal or
family history of arrhythmias, and children with a personal or family history of arrhythmias. The
corresponding questionnaires consist of 54, 56, 42 and 38 questions respectively. All
questionnaires have demographic, medical, genetic testing, life restriction, discrimination and
genetic knowledge questions, in addition to specific validated instruments (Table S1).

Outcome measures
Several validated scales were included in the adult patient survey which are the primary
outcome measures of this study. The MICRA questionnaire and the IES identify the impact of
genetic test results, while the SWDS determines satisfaction with having or not having genetic
testing. Understanding of genetic testing was also analyzed. Secondary outcome measures
include the influence of age and genetics knowledge on the primary outcome measures.
The MICRA Questionnaire
The MICRA questionnaire was developed in 2002 as a way to assess the specific impact
of result disclosure after cancer genetic testing. It sought to fill gaps left by other standardized
questionnaires of the time, by asking specific questions about one's test result and assessing the
impact it has on cancer risk as well. This validated tool consists of 25 questions, each with four
possible responses: never, rarely, sometimes and often. The questions are to be answered based
on feelings within the week of completing the questionnaire. There are 21 questions that must be
answered by all participants and four questions that are answered depending on one's parental
status, test results and cancer diagnosis. The MICRA questionnaire is composed of three
subscales that assess distress, uncertainty, and positive experiences (Cella et al., 2002). The
questions in this study were modified to be relevant for our patient population, substituting
'cardiac disease risk' in place of 'cancer risk' where appropriate.
The Impact of Events Scale
The IES was developed over 35 years ago to measure subjective distress in response to a
specific event. This scale is a short, easily administered self-report questionnaire that is
composed of 22 questions. It contains three subscales: intrusion (intrusive thoughts, nightmares,
intrusive feelings and imagery), avoidance (numbing of responsiveness, avoidance of feelings,

situations, and ideas) and hyperarousal (anger, irritability, hypervigilance, difficulty
concentrating, and heightened startle). The IES is a widely used, validated screening tool that
measures stress reactions after traumatic events such as natural disasters, war, terrorist attacks, or
sexual/physical assault, among other things. It can be used repeatedly to assess distress in
response to an event over time and allows investigators to examine the degree of distress
imposed by a particular life event in different populations of individuals, giving it the potential to
provide valuable information in a variety of situations (Horowitz, Wilner & Alvarez, 1979).
The Satisfaction with Decision Scale
The SWDS was designed to measure satisfaction with respect to health care decisions. It
has three major purposes: 1) to measure satisfaction with the decision, ensuring the decision is
informed, consistent with the individual’s values, and behaviourally implemented; 2) to
distinguish satisfaction with decision from satisfaction with other aspects of health care; and 3)
to be short and easy to use. This six-item scale is a reliable and valid instrument that is closely
related to a patient’s intention to act. It can also be used to gauge an individual’s contentment
with a decision they have already made (Holmes-Rovner et al., 1996).
Data analysis
The data was collected and organized through Survey Monkey and Microsoft Excel. IBM
SPSS Statistics was used to analyze the data. The MICRA questionnaire, IES and SWDS were
analyzed for internal consistency with Cronbach’s alpha. The mean, standard deviation, and
range were calculated for each scale. A linear regression was performed to analyze outcomes
measures comparative to age and genetics knowledge. P values were based on the KruskalWallis test.

5. RESULTS
A total of 91 unique families were invited to participate in the study. Within these
families, 141 individuals were reached. From those reached, 106 individuals consented to
participate in the study and each was sent a survey to complete. Of those who agreed to
participate, 61 individuals completed the survey. Accordingly, 45 individuals consented to
complete a survey, but did not. One individual was considered to have actively declined as she
indicated she was not interested in participating. There were four confirmed passive declines and
16 unconfirmed passive declines. Six individuals did not speak English and two did not have
working contact information. Unfortunately, one individual had passed away at the time of
contact. Based on the above numbers, the enrollment rate (individuals consented/individuals
invited) is 75% and the response rate (surveys completed/individuals invited) is 43%.
Of the 61 completed surveys, 36 were adult patient, 16 were child, five were adolescent
and four were adult married-in surveys. A total of four surveys were partially completed; one
was an adult patient, one was a child and two were adult married-in surveys.
Demographics
With regard to the adult patient population, 37 individuals started the questionnaire. It
was fully completed by 36 individuals, while one left it partially complete. All 37 participants
answered the demographics section. Of these 37 participants analyzed, the mean age was 41 with
a range of 19 to 62 years. With respect to gender, 62% were female and 38% were male. In terms
of race, 81% of participants identified as White. In regards to country of origin, 70.3% of
participants were born in the United States of America. Other countries of origin include
Romania (2.7%), Palestine (8.1%), Dominican Republic (2.7%), South Korea (2.7%),
Montenegro (2.7%), Germany (2.7%), The Philippines (2.7%), The Netherlands (2.7%), and

Hungary (2.7%). When asked about educational background, 35% of individuals indicated they
had received a Master's/Doctoral/some graduate degree. With regard to employment, 68% of
participants reported being employed full time (Table I).
The MICRA questionnaire
The MICRA questionnaire was completed by 35 of the 37 participants, as two individuals
indicated they did not have genetic testing and it was not applicable to complete the MICRA
questionnaire. The internal reliability of the subscales had high internal consistency, except for
the positive experiences subscale which had a split-half reliability coefficient of 0.53. The mean
of the distress subscale was 3.0. The mean of the uncertainty subscale was 5.4. The mean of the
positive experience subscale was 7.4 (Table II).
The IES
The IES was completed by 34 of the 37 participants. Two individuals did not have
genetic testing and therefore this scale was not applicable. One individual failed to complete this
scale as they only partially completed the survey. All of the subscales had high internal
consistency. The mean of the intrusion subscale was 3.2. The mean of the avoidance subscale
was 3.6. The mean of the hyperarousal subscale was 1.8 (Table II).
The SWDS
The SWDS was completed by 36 of the 37 participants. One individual failed to complete
this scale as they only partially completed the survey. The reliability was very high at 0.99. The
mean score for this scale was 20.8 (Table II).
Primary outcome measures
The IES has a scoring range of 0-88. The minimum stress score for the scale as a whole
was zero, the maximum was 48 and the mean was 8.6. The SWDS has a scoring range of 5-25.

The minimum score regarding satisfaction with decision was five, the maximum was 25 and the
mean was 20.8. The MICRA questionnaire has a scoring range of 0-125. The minimum score
was one, the maximum score was 69 and the average score was 24.0 (Table III).
A total of nine participants (24.3%) had a positive result, 24 (64.9%) had a negative result
and four (10.8%) did not have testing. Individuals who had a VUS were categorized as either
negative or positive depending on the pathogenicity of the specific variant.
Genetic test results do appear to have a significant impact on stress scores as the mean
stress scores for individuals with a positive result were elevated over those with negative results
for all three IES subscales as well as the IES as a whole. Additionally, individuals who did not
have genetic testing had stress scores that were higher than individuals with negative results, but
less than individuals with positive results (Table IV).
Overall, genetic test results were seen to have a significant effect on the psychological
impact of testing for cardiac disease risk. There was a significance seen with the uncertainty and
distress subscales of the MICRA questionnaire as well (p<0.05 for MICRA questionnaire total,
Uncertainty and Distress subscales). Genetic test results were not seen to have a significant
impact on positive experiences regarding the testing process for cardiac disease (Table IV).
Genetic test results do not appear to have a significant effect on an individual’s
satisfaction with their decision to either have or not have genetic testing, nor do they have any
impact on a participant’s genetic knowledge (Table IV).
Thirty-five individuals completed question 22 of the adult patient survey which asked if
participants felt sufficiently informed when undergoing genetic testing. Thirty-two of the 35
individuals (91.4%) felt sufficiently informed when they had genetic testing. Only three
individuals (8.6%) felt as though they understood what it meant to have genetic testing, but more

information would have been helpful. Unfortunately, the option to elaborate on additional
information that might have been helpful was not available. None of the participants felt as
though they had not been sufficiently informed at the time of testing, nor did anyone feel unsure
of the information provided, or not realize that genetic testing was performed (Figure 1).
Secondary Outcome Measures
Age was not seen to have an impact on stress scores, psychological impact of cardiac
disease diagnosis, one’s satisfaction with their decision or one’s genetic knowledge as p >0.05
for all measures (Table V).
Genetic knowledge was not seen to have a significant impact on stress scores,
psychological impact of cardiac disease risk or satisfaction with one’s decision as p>0.05 for all
measures (Table VI).

6. DISCUSSION
The goal of this study was to describe the experiences of a population of patients who
have undergone genetic testing for primary arrhythmic disorders, focusing on the psychological
outcomes and HR-QoL. In addition, this study aimed to examine participants’ understanding of
their results as well as assess their knowledge with regard to genetic concepts.
Understanding
Most participants correctly reported their genetic test results suggesting that genetic
counseling and results disclosure were sufficient and effective. With that being said, some
discrepancies were seen. Two participants reported having negative genetic testing results, when
in fact, no testing was conducted. Participants who did not have genetic testing should have
skipped questions involving the MICRA questionnaire and the IES. Because these individuals

thought they underwent genetic testing, they provided answers to questions regarding their
experience with genetic testing without ever actually having an experience to draw upon. This is
evident in Table IV where the “No Testing” category for the MICRA questionnaire and IES
should be blank, yet the data present is an average of the responses of these two individuals.
All 35 participants indicated that they were aware that they were having genetic testing.
Thirty-two of these individuals said they were given sufficient information to understand what
that meant while the remaining three individuals felt as though they understood, but more
information would have been helpful. When asked to recall the results of their genetic testing,
the majority (31/35) of participants reported results that were consistent with those found in the
Columbia University Medical Center database. Four individuals reported results that were
inconsistent for different reasons. As mentioned above, two participants reported having negative
genetic testing results, when in fact, no testing was conducted. One indicated that his result was
uncertain, yet the database showed that he had a negative result. One individual reported that the
results of the testing were unclear to her, but her results in the database were negative. This
individual was the only one to indicate that she did not understand her genetic testing results,
while the other three individuals, who clearly did not understand, claimed that they did. This
suggests that there was not sufficient information provided to these individuals during their
genetic counseling sessions for them to fully understand their results.
The MICRA questionnaire
Overall, the participants receiving genetic testing for arrhythmias did not report negative
psychological experiences on the MICRA questionnaire, with an average score of 24. Only one
individual had a score greater than 50% of the maximum score at 69/125. This is the highest

score seen within the cohort and may suggest that this individual is at an increased risk for future
distress.
In general, those with negative results or those who did not undergo genetic testing were
seen to have lower average scores than those who tested positive, which was significant
(p<0.05). On average, these participants reported rarely feeling distressed or uncertain about
their genetic test results within the last week, with an average score of 3.0.
The IES
The average stress score following genetic testing as reported on the IES was 8.6 out of a
maximum of 88 points. Of the 34 participants, 12 (35%) reported an overall stress score of zero
and 23 (67%) reported a score less than 10. Accordingly, the majority of participants experienced
little to no distress for each of the 22 difficulties listed on the IES that are commonly
encountered after stressful life events. For this scale, scores that exceed 24 can be quite
meaningful. For a score greater than 24, post-traumatic stress disorder (PTSD) becomes a
clinical concern, a score of 33 is the best cutoff for a probable diagnosis of PTSD, and a score
that exceeds 37 is enough stress to suppress immune system functioning. Of the 34 respondents,
four individuals reported scores above 24. Three of these individuals had received a positive
result and their stress scores were 29, 41 and 48. The fourth individual had not had genetic
testing and reported a stress score of 34, however it should be noted that this individual believed
that she had genetic testing and was negative. In general, this trend suggests that participants
with positive results were more likely to have significant stress scores.
It was also found that genetic testing status (testing versus no testing) and genetic test
result have a significant impact on stress score for all three IES subscales as well as the IES as a
whole. Individuals with negative results had the lowest stress scores, individuals with positive

results had the highest stress scores and individuals who had not had genetic testing had stress
scores in between these. A comparison of stress scores for positive results with those for no
genetic testing shows that these values are quite similar, which is expected.
Additionally, participants who completed the IES were categorized into two groups
depending on whether they themselves were the proband or if their child was the proband. The
average overall stress score for participants whose child was the proband was 9.58, which is
slightly higher than the stress score of 7.67 for participants who were the proband. This suggests
that adults were slightly more stressed if it was their children who came to medical attention
first, rather than themselves.
The SWDS
Of the 36 participants who completed the SWDS, 31 (86%) were satisfied with their
decision to either have or not have genetic testing. One individual was neither satisfied nor
dissatisfied with their decision, and four individuals were not satisfied with their decision. Of
these four, three were negative and one was positive. This suggests that test result does not alter
one’s satisfaction with their decision, especially because the individuals who are dissatisfied are
not all positive, which one would assume would be the group most likely to be dissatisfied.
Further examination of responses to other survey questions for each of these four individuals did
not identify any commonalities as to why they would all be dissatisfied.
The average overall satisfaction score for participants whose children were the probands
was 21.17, which is essentially no different than the satisfaction score of 21.47 for participants
who were the probands.

Limitations
As this was a pilot study, limitations were noted during this process. Due to constraints at
the start of the project, we were only able to collect data on 37 individuals. While this is a good
starting point to analyze trends in the data, a larger cohort is needed to allow for more detailed
analysis and greater generalizability of the results.
The IES consists of a list of 22 difficulties that people may experience after distressing
life events. Participants are typically asked to assess how distressing each difficulty has been
within the last week since the occurrence of the event. In our study however, the life event of
genetic testing occurred anywhere between three months to seven years ago. Accordingly, it is
possible that having more time pass since the testing has dulled the emotions, feelings, worries or
concerns. Participants have returned to daily life and it is possible that they do not experience
things as intensely as they likely had one week after testing which is the time frame this scale is
typically used for. Similar limitations are present with the MICRA questionnaire as well.
The data was stratified to look at those who were tested within a year versus those tested
outside a year. While it is uncertain if this is statistically significant, differences were seen in
both the average MICRA questionnaire and IES scores. Individuals tested within a year had an
average MICRA questionnaire score of 28.9 and an average IES score of 12.1. Those tested
outside of a year had an average MICRA questionnaire score of 22.5 and an average IES score of
7.6. Despite this observation, the highest and lowest MICRA questionnaire scores and the
highest IES score were seen in individuals who were tested more than a year ago. Accordingly, it
is uncertain what the difference in average scores means, if anything.
A difficulty that was encountered throughout the project was completion of the
questionnaire following the consent process. Follow up was done through email, so there is a

chance that the survey links and/or follow up emails did not reach the participants, with the
possibility of emails being transferred to a participant’s junk email folder.
One limitation with the questionnaire itself was that it had to be completed in one sitting.
Most individuals were able to do so; however, there were a few who did not realize this and
would leave the survey partially completed.
Lastly, many of the validated instruments ask participants to think back to when they
received their genetic testing results. Some individuals did not remember receiving genetic
testing results and this would influence their response to those questions.
Implications for practice
By understanding what factors cause patients to become more anxious following genetic
testing, we can help prepare them for what may arise after testing and results disclosure by
addressing these factors beforehand during the pre-test counseling. Additionally, knowing if a
patient is highly anxious prior to the session may influence HR-QoL and psychological wellbeing following results disclosure. This enables genetic counselors to tailor their sessions
appropriately and employ counseling techniques that can better prepare the patient for the
potential impact of their results.
Implications for future research
This study, which assessed psychosocial outcomes for individuals who had genetic
testing for primary inherited arrhythmias, was the first pilot study of its kind. It was designed to
assess baseline levels of psychological impact within an adult population. Future studies can be
more focused on different groups of individuals, assessing for certain hypotheses.

Conclusion
Through this study, we were able to see correlations between a genetic testing result and
the degree of psychological impact of that result, whether through stress scores or level of
anxiety surrounding cardiac disease risk. In general, higher stress scores were seen for those who
were positive, yet the majority of individuals reported receiving adequate information during
their genetic testing process with minimal psychological impact. This shows that the amount of
information provided to a patient during a genetic counseling session is sufficient for patients
and results in relatively few psychological effects. Future studies that utilize a larger patient
population will allow for more meaningful results with respect to HR-QoL and psychological
well-being, as well as additional relevant psychological outcomes. In turn, these results have the
ability to impact clinical management and results disclosure sessions while also enhancing
patient education and increasing awareness of the genetic counseling field.
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Table I: Adult Demographics
Demographic

Options

N

%

Gender

Male
Female
Below 50
Above 50
White
Black/African American
Asian/Pacific Islander
American Indian/Alaska Native
Hispanic/Latino/Spanish
Other
Did not graduate high school
High school graduate or GED
Some college (vocational, technical, associate’s
degree etc.)
College Graduate
Master’s degree/Doctoral degree/some graduate
degree
Employed full-time

14
23
28
9
30
0
2
0
3
2
1
3
11

37.8
62.2
75.7
24.3
81.1
0
5.4
0
8.1
5.4
2.7
8.1
29.7

9
13

24.3
35.1

25

67.6

Working for wages or salary part-time
Unemployed or laid off
Keeping house or raising children full-time
Temporarily disabled
Other

4
1
3
1
3

10.8
2.7
8.1
2.7
8.1

Age
Race

Highest level of education

Main daily activities and/or
responsibilities

Table II: Internal consistency of the MICRA questionnaire, IES and SWDS and subscale results

MICRA Distress
MICRA Uncertainty
MICRA Positive
Experiences
IES Intrusion
IES Avoidance
IES Hyperarousal
SWDS

Cronbach’s alpha

Mean

Standard Deviation

Range

0.85
0.79
0.80

3.0
5.4
7.4

5.0
6.8
6.3

0-22
0-25
0-20

0.92
0.88
0.90
0.99

3.2
3.6
1.8
20.8

4.9
5.1
3.3
6.0

0-19
0-22
0-13
5-25

Table III: Summary of Outcome Measures

IES Intrusion
IES
Avoidance
IES
Hyperarousal
IES Total
SWDS
MICRA
Distress
MICRA
Uncertainty
MICRA
Positive
Experiences
MICRA Total
Genetic
Knowledge

N

%

Mean

St Dev

Min

Max
19
22

95% CI
low
1.5
1.8

95% CI
high
4.9
5.3

34
34

91.9
91.9

3.2
3.6

4.9
5.1

0
0

34

91.9

1.8

3.3

0

13

0.7

3.0

34
36
35

91.9
97.3
94.6

8.6
20.8
3.0

12.3
6.0
5.0

0
5
0

48
25
22

4.2
18.7
1.2

12.9
22.8
4.7

35

94.6

5.4

6.8

0

25

3.1

7.7

35

94.6

7.3

6.3

0

20

5.2

9.5

35
36

94.6
97.3

24.0
8.5

15.3
1.8

1
4

69
10

18.8
7.9

29.3
9.1

Table IV: Relationship between outcome measures and genetic test results (all patients)
Genetic
Testing,
Positive (1)
IES Intrusion
IES Avoidance
IES
Hyperarousal
IES Total
SWDS
MICRA
Distress
MICRA
Uncertainty
MICRA
Positive
Experiences
MICRA Total
Genetic
Knowledge

Genetic Testing,
Negative (2)

No Genetic
Testing

Non-parametric
group comparison
(p) with ties

Mean
7.4
7.3

SD
5.8
6.7

Mean
0.77
1.9

SD
1.7
3.3

Mean
8.0
4.7

SD
7.0
5.7

P value
p<0.001
p<0.01

4.7

4.8

0.45

1.1

3.3

4.2

p<0.001

19.4
20.9
7.7

16.1
6.4
7.6

3.1
20.4
1.4

4.9
6.4
2.2

16.0
22.5
0.67

16.7
2.9
0.58

p<0.01
p=0.93
p<0.01

10.9

7.5

4.0

5.7

0.33

0.58

p<0.05

6.3

4.4

7.1

7.0

12.3

3.2

p=0.28

38.1

16.9

19.8

12.0

14.7

4.6

p<0.05

8.6

1.3

8.4

2.1

8.5

1.7

p=0.97

Table V: Linear Regression of Outcome Measures vs. Age
Constant

Coefficient for age

P value

IES Intrusion

8.3

-0.12

0.14

IES Avoidance

9.5

-0.14

0.09

IES Hyperarousal

5.4

-0.09

0.12

IES Total

23.3

-0.35

0.09

SWDS

18.8

0.05

0.61

MICRA Distress

3.8

-0.02

0.81

MICRA Uncertainty

4.5

0.02

0.85

MICRA Positive
Experiences

9.3

-0.05

0.66

MICRA Total

24.8

-0.02

0.94

Genetic Knowledge

8.4

0.00

0.92

Table VI: Linear Regression of Outcome measures vs. Genetic Knowledge
Constant

Coefficient for
knowledge

P value

IES Intrusion

1.83

0.16

0.73

IES Avoidance

5.18

-0.19

0.69

IES Hyperarousal

0.73

0.13

0.68

IES Total

7.74

0.10

0.94

SWDS

24.77

-0.47

0.41

MICRA Distress

1.75

0.14

0.77

MICRA Uncertainty

1.70

0.43

0.51

MICRA Positive
Experiences

6.54

0.11

0.85

MICRA Total

19.16

0.55

0.71

Figure 1. Question 22 - Did you feel sufficiently informed when you underwent genetic testing?

Supplementary Tables
Table S1: Study instruments utilized in each of the four questionnaires
Instrument

Adult
Proband

Adult
Married in

Adolescent Child Reference

Demographic

X

X

X

X

Medical

X

X

X

X

Genetic Testing

X

X

X

X

Life Restriction and Discrimination
Questions

X

X

X

X

Genetic Knowledge

X

X

X

X

Impact of Event Scale

X

X

X

Satisfaction with Decision
Instrument

X

Multidimensional Impact of Cancer
Risk Assessment Questionnaire

X

X

3

Beck Anxiety Inventory

X

X

4

1
X

Beck Depression Inventory I
Wakefield Questionnaire

5
X

X

6

McMaster Family Assessment
Device (General Functioning
Subcategory)
Kansas Marital Satisfaction Scale

7

X

X

8

Intolerance of Ambiguity Scale

9

Vulnerability Child Scale

X

Scale to Assess Child’s Physical and
Psychological Health

X

1.
2.
3.
4.
5.

2

http://consultgerirn.org/uploads/File/trythis/try_this_19.pdf
http://umg.umdnj.edu/smdm/pdf/16-01-058.pdf
http://www.primarycarecore.org/pdf/90.pdf
https://dih.wiki.otago.ac.nz/images/8/80/Beck.pdf
http://www.ibogaine.desk.nl/graphics/3639b1c_23.pdf

10

6.
7.
8.

9.
10.

http://www.namigc.org/documents/selfreportquestionaire.pdf
http://onlinelibrary.wiley.com/doi/10.1111/j.1752-0606.1983.tb01497.x/pdf
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CCUQFjAA&url=http%3A%2F%2Flearners.n
cu.edu%2Fsyllabus%2Fdownload_file.asp%3Fsyllabus_rr_id%3D144848&ei=_rZXVLnFGazjsATR84HwAw&usg=AFQjCNE
Ci2n275Nu3YH53rCLu3syrG8ldA&sig2=eimgkcLmM31i82ZbUqMEFg
http://www4.ncsu.edu/unity/users/p/padilla/www/435-Leadership/Scale-%20tolerance%20of%20ambiguity.pdf
http://jpepsy.oxfordjournals.org/content/21/1/89.long

